fbpx

Year

2019
Lund, Sweden, 08.00 CET, 27 February 2018 – BONESUPPORT HOLDING AB (publ) – listed on Nasdaq Stockholm – an emerging leader in orthobiologics for the management of bone voids, today publish the financial report for the fourth quarter and the full year 2018. POSITIVE RESULTS FROM THE CERTIFY STUDY AND CONTINUED STRONG GROWTH IN EUROPE 1 OCTOBER–...
Cambridge, UK and Indianapolis, US – 27 February 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients, announces its results for the year ended 31 December 2018. A conference...
Phase 1 top-line data readout for oral SPR720 expected in second half of 2019 CAMBRIDGE, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial infections, announced today that SPR720, an orally administered antimicrobial agent being developed for the...
Cambridge, UK and Indianapolis, US – 25 February 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients, will announce its results for the full year ended 31 December 2018 on Wednesday 27...
Lund, Sweden, 08.00 CET, 22 February 2019 – BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, today announces the publication of new data on antibiotic release from CERAMENT® V in a clinical study. The study ‘Vancomycin elution from a biphasic ceramic bone substitute’ is published in Bone Joint Research (Bone Joint...
Lund, Sweden, 08.00 CET, 20 February 2019 – BONESUPPORT HOLDING AB (publ) -listed on Nasdaq Stockholm – an emerging leader in Orthobiologics for the management of bone voids, invites to a conference call at 10.00 am on 27 February in connection of the Full Year Report 2018, which is published the same day at 08.00...
Between 1,200 and 3,000 Danes suffer from narcolepsy, as this disorder is called. During the sudden attacks, sufferers experience an extreme craving for sleep. New Danish research indicates that narcolepsy is an autoimmune disorder.  An autoimmune disease is when the body attacks itself, as it does, for instance, in the case of arthritis or psoriasis....
Chapel Hill, NC and Ness Ziona, Israel – February 14, 2019 – Atox Bio, a clinical stage company developing novel therapies for critically ill patients, today announced the appointment of Robert Greif as Chief Commercial Officer. In this newly created position, Robert will be responsible for building the commercial organization and pre-commercial activities for Reltecimod,...
Lund, Sweden, 08.00 CET, 08 February 2019 – BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, today announces the publication of ground-breaking data on bone remodeling of CERAMENT in pre-clinical model. The study ‘Establishment and effects of allograft and synthetic bone graft substitute treatment of a critical size metaphyseal bone defect...
CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections, today announced the acceptance by the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for SPR994,...
1 9 10 11 12 13

News

How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020
A 60-year-old’s muscles aren’t old at all
23. March 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge